8-K: BiomX Inc. Amends Note, Issues Stock to Water IO Ltd.
Current Report (8-K)
BiomX Inc. has amended a promissory note with Water IO Ltd., extending the maturity date and issuing restricted stock as consideration for accrued interest and payment delay.
Summary
- BiomX Inc. has entered into an amendment and waiver agreement with Water IO Ltd. regarding a $1,250,000 promissory note originally issued on April 10, 2026.
- The maturity date of the note has been extended from July 10, 2026, to November 1, 2026.
- BiomX will pay $250,000 in principal within two business days of the amendment's execution.
- The remaining principal will be paid in four equal monthly installments of $250,000 on August 1, September 1, October 1, and November 1, 2026.
- As consideration for the delay and waiver, BiomX will issue 800,000 restricted shares of its common stock to Water IO Ltd., subject to NYSE American listing approval and corporate confirmations by August 31, 2026.
- If the share issuance conditions are not met by August 31, 2026, the accrued interest will be paid in cash with the final installment.
- Water IO Ltd. has waived any default or acceleration rights related to the original maturity date non-payment.
- The shares issued will be unregistered, restricted securities under Section 4(a)(2) and Regulation S of the Securities Act of 1933.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral; while it addresses a past-due obligation and provides a path forward, it involves debt extension, potential dilution through stock issuance, and a tight deadline for listing approvals.
Positives
- Extension of the note maturity date provides additional time for BiomX to manage its cash flow.
- Water IO Ltd. has waived any default, providing a clear path forward for the amended payment schedule.
- The issuance of stock as partial consideration may reduce immediate cash outflow for BiomX.
- The company received necessary board and audit committee approval, including for a related party transaction.
Negatives
- The company is deferring a portion of its principal payment and paying interest on the outstanding balance.
- Issuance of 800,000 restricted shares dilutes existing shareholders' equity.
- The company faces a deadline of August 31, 2026, for listing application clearance and corporate approvals for the stock issuance, otherwise, cash payment for interest is required.
Risks
- Failure to obtain NYSE American listing clearance for the 800,000 shares by August 31, 2026, will result in a cash payment of accrued interest.
- The company's ability to make the scheduled monthly principal payments of $250,000 from August to November 2026 is a potential risk.
- The shares issued are restricted and cannot be immediately sold by Water IO Ltd., but their future sale could impact market price.
- A related party transaction exists, as an independent director of BiomX also serves as an independent director of Water IO Ltd.
Future Outlook
The company has extended the maturity of a promissory note and outlined a payment schedule including cash installments and a potential stock issuance. The successful issuance of stock is contingent on NYSE American listing clearance and corporate approvals by August 31, 2026, otherwise, accrued interest will be paid in cash.
Management Comments
- The amendment was approved by the Company's Board of Directors, including the Audit Committee, in accordance with the Company's related person transaction policy, with the interested director abstaining.
Industry Context
StockSavvy.ai notes that this amendment reflects common strategies for companies managing debt obligations post-acquisition, particularly when facing short-term liquidity pressures. The use of stock as consideration is a typical tool to conserve cash, though it introduces dilution concerns for existing shareholders.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Related Party Transaction Approval | The amendment and waiver was approved by the Company's Board of Directors and Audit Committee in accordance with the related person transaction policy, with the interested director abstaining. | July 24, 2026 | Ensures compliance with corporate governance standards for transactions involving interested parties. |
Related Party Transactions
- An independent member of BiomX Inc.'s Board of Directors also serves as an independent director of Water IO Ltd., the holder of the promissory note.
Stakeholder Impact
- Shareholders: Potential dilution from the issuance of 800,000 restricted shares.
- Creditors: The amendment provides clarity on the repayment schedule of a significant debt obligation.
- Water IO Ltd.: Receives an extension on the note maturity and consideration in the form of cash and potentially restricted stock.
Next Steps
- BiomX Inc. to pay $250,000 principal within two business days of amendment execution.
- BiomX Inc. to make four equal monthly principal payments of $250,000 starting August 1, 2026.
- BiomX Inc. to seek clearance of an additional listing application with NYSE American for 800,000 shares.
- Both parties to provide written confirmation of corporate approvals by August 31, 2026, for share issuance.
- If conditions are not met by August 31, 2026, accrued interest will be paid in cash with the final installment.
Key Dates
| Date | Description |
|---|---|
| 2026-04-10 | Original issuance date of the promissory note and completion of ZorroNet Ltd. acquisition. |
| 2026-07-07 | Original maturity date of the promissory note. |
| 2026-07-24 | Date of Amendment No. 1 and Waiver to Promissory Note. |
| 2026-07-27 | Date of the 8-K filing reporting the amendment. |
| 2026-08-01 | First monthly installment payment due for the remaining principal. |
| 2026-08-31 | Longstop date for clearance of additional listing application and corporate confirmations for share issuance. |
| 2026-11-01 | Extended maturity date of the promissory note and final principal installment due. |
Recommendation
holdThe filing indicates a renegotiation of debt, which is a common occurrence. While the extension and stock issuance are not inherently positive or negative, the potential dilution and the contingent nature of the stock issuance (dependent on listing approval) warrant a cautious 'hold' stance until further clarity on the stock issuance and the company's ability to meet future payments is available.
Keywords
Promissory Note Amendment, Material Definitive Agreement, Restricted Stock Issuance, Debt Restructuring, Water IO Ltd., ZorroNet Ltd. Acquisition, BiomX Inc., NYSE American Listing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.